NCT07667257

Brief Summary

This prospective observational study aims to investigate the effect of preoperative central sensitization on postoperative clinical outcomes in patients undergoing arthroscopic rotator cuff repair. Central sensitization, characterized by an increased responsiveness of the central nervous system to pain stimuli, has been associated with persistent pain and poor functional recovery in various musculoskeletal disorders. However, its impact on outcomes following arthroscopic rotator cuff repair has not been fully elucidated. Adult patients diagnosed with a rotator cuff tear by clinical examination and magnetic resonance imaging (MRI) and scheduled for arthroscopic repair will be enrolled. Preoperative central sensitization will be assessed using the Central Sensitization Inventory (CSI), while pain intensity and shoulder function will be evaluated using the Visual Analog Scale (VAS) and the Shoulder Pain and Disability Index (SPADI), respectively. Clinical assessments will be performed preoperatively and at postoperative 3 months. The study aims to determine whether preoperative central sensitization is associated with postoperative pain and functional recovery after arthroscopic rotator cuff repair.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
5mo left

Started Jun 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Jun 2026Dec 2026

First Submitted

Initial submission to the registry

June 12, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 25, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

June 30, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2026

Expected
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

June 25, 2026

Status Verified

June 1, 2026

Enrollment Period

6 months

First QC Date

June 12, 2026

Last Update Submit

June 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Primary Outcome: Change in SPADI Total Score

    The primary outcome is the change in the total Shoulder Pain and Disability Index (SPADI) score from baseline to postoperative 3 months. The SPADI assesses shoulder pain and disability and consists of pain and disability subscales. The total score ranges from 0 to 100, with higher scores indicating greater shoulder pain and disability. Lower scores indicate better shoulder function and less pain. The change will be compared according to preoperative central sensitization status.

    Baseline (preoperative) and postoperative 3 months

Secondary Outcomes (2)

  • Change in Visual Analog Scale (VAS) Pain Score

    Baseline (preoperative) and postoperative 3 months

  • Change in Central Sensitization Inventory (CSI) Score

    Baseline (preoperative) and postoperative 3 months

Study Arms (2)

Patients With Central Sensitization

Patients with a preoperative Central Sensitization Inventory score of ≥40.

Procedure: Arthroscopic Rotator Cuff Repair

Patients Without Central Sensitization

Patients with a preoperative Central Sensitization Inventory score of \<40.

Procedure: Arthroscopic Rotator Cuff Repair

Interventions

All enrolled patients will undergo standard arthroscopic rotator cuff repair according to institutional clinical practice. The study is observational, and no additional intervention will be administered as part of the research protocol.

Patients With Central SensitizationPatients Without Central Sensitization

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of adult patients aged 18-65 years with a rotator cuff tear confirmed by clinical examination and magnetic resonance imaging (MRI) who are scheduled to undergo arthroscopic rotator cuff repair at the Department of Orthopedics and Traumatology of a single tertiary care center. Eligible patients who meet the inclusion criteria and provide written informed consent will be consecutively enrolled. Preoperative and postoperative clinical evaluations, including assessment of central sensitization, pain, and shoulder function, will be performed according to the study protocol.

You may qualify if:

  • Age between 18 and 65 years
  • Diagnosis of rotator cuff tear confirmed by clinical examination and magnetic resonance imaging (MRI)
  • Scheduled to undergo arthroscopic rotator cuff repair
  • Ability to understand and complete study questionnaires
  • Willingness to participate and provide informed consent

You may not qualify if:

  • Previous surgery on the affected shoulder.
  • Concomitant shoulder disorders requiring additional surgical procedures (e.g., fracture, instability, advanced glenohumeral osteoarthritis).
  • History of inflammatory rheumatic disease, active infection, or malignancy affecting the shoulder.
  • Neurological disorders that may influence pain perception or upper extremity function.
  • Severe psychiatric illness or cognitive impairment preventing completion of the questionnaires.
  • Pregnancy.
  • Inability or unwillingness to provide written informed consent.
  • Inability to attend the postoperative 3-month follow-up evaluation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Rotator Cuff Injuries

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon Injuries

Study Officials

  • Erdal Güngör, M.D

    Istanbul Medipol University, Department of Orthopedics and Traumatology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Erdal Güngör, M.D

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator Official Title:

Study Record Dates

First Submitted

June 12, 2026

First Posted

June 25, 2026

Study Start

June 30, 2026

Primary Completion (Estimated)

December 15, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

June 25, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be made publicly available.